Evidence map›Paper›PMID 11495812›Full record

ReviewCurrent opinion in microbiology2001

Mouse hepatitis virus.

J Haring, S Perlman

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in microbiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. Review
  3. Human coronaviruses: activation and antagonism of innate immune responses.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Interaction between coronaviruses and the autophagic response.Frontiers in cellular and infection microbiology · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Evidence for SARS-CoV-2 Infection of Animal Hosts.Pathogens (Basel, Switzerland) · 2020
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

J HaringDepartments of Microbiology and Pediatrics, University of Iowa, Medical Laboratories 2042, Iowa City, IA 52242, USA. jodie-haring@uiowa.edu
S Perlman
University of Iowa · US

Funding

Role of microglia in MHV-induced demyelinationR01NS036592 · NINDS · UNIVERSITY OF IOWA · PI PERLMAN, STANLEY · 1997 to 2021
$6.0M
IMMUNOPATHOGENESIS OF VIRUS-INDUCED DEMYELINATIONR01NS040438 · NINDS · UNIVERSITY OF IOWA · PI PERLMAN, STANLEY · 2000 to 2003
$1.0M
ANTIGEN SPECIFIC T CELLS IN INFLAMED CNSR03AI043497 · NIAID · UNIVERSITY OF IOWA · PI PERLMAN, STANLEY · 1998 to 2000
$74k
NIAID NIH HHS AI43497NIAID NIH HHS P32 AI 07533NINDS NIH HHS NS36592NINDS NIH HHS NS40438
6 · The paper itself

Abstract

Inoculation of mice with most neurotropic strains of the coronavirus mouse hepatitis virus results in an immune response-mediated demyelinating disease that serves as an excellent animal model for the human disease multiple sclerosis. Recent work has shown that either virus-specific CD4(+) or CD8(+) T cells are able to mediate demyelination and also that the antibody response is crucial for clearing infectious virus. Another exciting advance is the development of recombinant coronaviruses, which, for the first time, will allow genetic manipulation of the entire viral genome.

Indexed as

Coronavirus InfectionsMultiple SclerosisAnimalsDisease Models, AnimalHumansMiceMurine hepatitis virus

Identifiers

PMID11495812
PMCPMC7129732
OpenAlexW1977400857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.